[go: up one dir, main page]

SV2006002290A - Nonadepsipeptidos acilados ii ref. bhc041327-sv - Google Patents

Nonadepsipeptidos acilados ii ref. bhc041327-sv

Info

Publication number
SV2006002290A
SV2006002290A SV2005002290A SV2005002290A SV2006002290A SV 2006002290 A SV2006002290 A SV 2006002290A SV 2005002290 A SV2005002290 A SV 2005002290A SV 2005002290 A SV2005002290 A SV 2005002290A SV 2006002290 A SV2006002290 A SV 2006002290A
Authority
SV
El Salvador
Prior art keywords
nonadepsipeptidos
bhc041327
acilados
ref
preparation
Prior art date
Application number
SV2005002290A
Other languages
English (en)
Inventor
Franz Von Nussbaum
Nina Brunner
Rainer Endermann
Chantal Fuerstner
Elke Hartmann
Holger Paulsen
Jacques Ragot
Guido Schiffer
Joachim Schuhmacher
Niels Svenstrup
Joachim Telser
Sonja Anlauf
Michael Alexander Bruning
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of SV2006002290A publication Critical patent/SV2006002290A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A NONADEPSIPEPTIDOS Y A PROCEDIMIENTOS PARA SU PREPARACION, ASI COMO A SU USO PARA LA PREPARACION DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DE ENFERMEDADES, ESPECIALMENTE ENFERMEDADES INFECCIOSAS BACTERIANAS
SV2005002290A 2004-11-05 2005-11-04 Nonadepsipeptidos acilados ii ref. bhc041327-sv SV2006002290A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004053407A DE102004053407A1 (de) 2004-11-05 2004-11-05 Acylierte Nonadepsipeptide II

Publications (1)

Publication Number Publication Date
SV2006002290A true SV2006002290A (es) 2006-10-13

Family

ID=35462537

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002290A SV2006002290A (es) 2004-11-05 2005-11-04 Nonadepsipeptidos acilados ii ref. bhc041327-sv

Country Status (27)

Country Link
US (1) US7531507B2 (es)
EP (1) EP1807443A1 (es)
JP (1) JP4843614B2 (es)
KR (1) KR20070083984A (es)
CN (1) CN101056887A (es)
AR (1) AR053775A1 (es)
AU (1) AU2005300815B2 (es)
BR (1) BRPI0516677A (es)
CA (1) CA2586704A1 (es)
CR (1) CR9079A (es)
DE (1) DE102004053407A1 (es)
GT (1) GT200500308A (es)
HN (1) HN2005030779A (es)
IL (1) IL182739A (es)
MA (1) MA29218B1 (es)
MX (1) MX2007005382A (es)
MY (1) MY145448A (es)
NO (1) NO20072854L (es)
NZ (1) NZ554813A (es)
PE (1) PE20060942A1 (es)
RU (1) RU2414477C2 (es)
SV (1) SV2006002290A (es)
TW (1) TW200621799A (es)
UA (1) UA89800C2 (es)
UY (1) UY29189A1 (es)
WO (1) WO2006048139A1 (es)
ZA (1) ZA200703674B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004051023A1 (de) * 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004051025A1 (de) * 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004051024A1 (de) * 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004053410A1 (de) * 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102006003443A1 (de) * 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018250A1 (de) * 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
DE102006018080A1 (de) * 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide
TW201717991A (zh) * 2015-08-17 2017-06-01 拜耳動物保健有限公司 用於治療牛乳房炎之溶桿菌素
CA3234750A1 (en) * 2015-10-23 2017-04-27 Navitor Pharmaceuticals, Inc. Modulators of sestrin-gator2 interaction and uses thereof
EP3363452A1 (en) * 2017-02-17 2018-08-22 Bayer Animal Health GmbH Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals
CA3061611A1 (en) 2017-04-26 2018-11-01 Navitor Pharmaceuticals, Inc. Modulators of sestrin-gator2 interaction and uses thereof
CN114786660A (zh) 2019-11-01 2022-07-22 纳维托制药有限公司 使用mtorc1调节剂的治疗方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266247A (en) 1985-03-25 1990-02-27 Adrienne A. Tymiak Antibiotic prepared from lysobacter sp. sc 14,067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンaおよびbならびにその製造法
DE10320781A1 (de) * 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide

Also Published As

Publication number Publication date
NO20072854L (no) 2007-08-01
DE102004053407A1 (de) 2006-05-11
RU2007120686A (ru) 2008-12-10
HN2005030779A (es) 2010-08-19
EP1807443A1 (de) 2007-07-18
US20060264358A1 (en) 2006-11-23
CA2586704A1 (en) 2006-05-11
RU2414477C2 (ru) 2011-03-20
JP2008518982A (ja) 2008-06-05
MA29218B1 (fr) 2008-02-01
IL182739A0 (en) 2007-07-24
UA89800C2 (en) 2010-03-10
NZ554813A (en) 2009-11-27
JP4843614B2 (ja) 2011-12-21
MY145448A (en) 2012-02-15
TW200621799A (en) 2006-07-01
PE20060942A1 (es) 2006-10-20
US7531507B2 (en) 2009-05-12
GT200500308A (es) 2006-06-02
AR053775A1 (es) 2007-05-23
KR20070083984A (ko) 2007-08-24
WO2006048139A1 (de) 2006-05-11
AU2005300815B2 (en) 2011-05-19
BRPI0516677A (pt) 2008-09-16
CR9079A (es) 2007-08-28
IL182739A (en) 2013-03-24
MX2007005382A (es) 2007-08-14
CN101056887A (zh) 2007-10-17
AU2005300815A1 (en) 2006-05-11
ZA200703674B (en) 2008-09-25
UY29189A1 (es) 2006-06-30

Similar Documents

Publication Publication Date Title
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
HN2004000146A (es) Dihidroquinazolinas sustituidas
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
UY30578A1 (es) Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones
HN2008001191A (es) Compuestos de biciclolactama sustituida
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
UY31484A1 (es) Piperidinas heteroaril-sustituidas
UY28313A1 (es) Nonadepsipeptidos acilados
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
UY28542A1 (es) Amidas macrocíclicas antibacterianas
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
HN2003000104A (es) Derivados de ciclopenteno
UY30046A1 (es) Nuevos derivados de furopirimidina acíclicos sustitiudos y su uso
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
HN2006007774A (es) Imidazoles sustituidos con heterociclilamida
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
DOP2005000250A (es) Amidas de acido pirazindicarboxilico y su uso

Legal Events

Date Code Title Description
FG Grant
FD Lapse